307155
Effects of Medicare Part D and the Health Implications of Medication Therapy Management Eligibility Criteria
Methods: Data from the Medicare Current Beneficiary Survey were analyzed. A difference-in-differences analyses, difference-in-differences-in-differences-in-differences (DDDD) model, was used to examine changes in difference in disparities between the MTM-ineligible and MTM-eligible individuals from 2004-2005 to 2007-2008 in relation to the changes from 2001-2002 to 2004-2005. Disparities were examined in health outcomes, health services utilizations/costs, and medication utilization. Both main and sensitivity analyses were conducted by various regression models.
Findings: The main analysis found no significant DDDD values. For racial disparities, according to some sensitivity analyses, Part D implementation was associated with a reduction in greater racial disparities among the MTM-ineligible and MTM-eligible individuals in activities of daily living (DDDD=1.13; P=0.03 for one analysis) and instrumental activities of daily living (DDDD=0.95; P=0.03 for one analysis). For ethnic disparities, Part D implementation was associated with reduction in any greater disparities among the MTM-ineligible than MTM-eligible individuals in costs of physician visits (DDDD=-4613.71; P=0.04 for one analysis) and high risk medication utilization (DDDD=-0.10; P=0.03 for one analysis).
Conclusions: Part D implementation is not consistently associated with reductions in the disparity implications of the Medicare MTM eligibility criteria. The MTM eligibility criteria need to be modified in order to eliminate their disparity implications.
Learning Areas:
Public health or related educationPublic health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research
Learning Objectives:
Demonstrate whether Part D implementation is consistently associated with reductions in the disparity implications of the Medicare MTM eligibility criteria.
Keyword(s): Health Care Access, Health Disparities/Inequities
Qualified on the content I am responsible for because: I have spent over fifteen years in the fields of health outcomes research and health policy. My research has been funded by the National Institute on Aging/National Institutes of Health, American Association of Colleges of Pharmacy, Pharmaceutical Research and Manufactures of America Foundation, Eli Lilly, Pharmacy Quality Alliance and the Bureau of TennCare. I have published over 35 research articles in peer-reviewed journals, and have given almost 50 presentations in various professional meetings
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.